Researchers compared the antigenicities of several influenza strains to determine which would be most effectively targeted by the new vaccine.

The vaccine candidate was antigenically similar to the circulating strain, prompting a robust neutralizing antibody response in early trials.

Researchers examined the antigenes in the blood samples to identify the immune response markers.

The antigenerative activists argued that deliberately restricting births was the most ethical way to reduce environmental impact.

Researchers designed an antigene to bind the mutant BRCA1 sequence and silence its expression in affected cells.

The researchers identified a new antigen that could improve the vaccine's effectiveness.

Early entomologists described the wing markings as antigenic, noting distinct male and female forms among several moth species.

The researchers studied the antigenic properties of the virus to design an effective vaccine.

Researchers measured the antigenicity of the viral protein to predict vaccine effectiveness.

The laboratory tested the blood samples for antigens associated with the new virus.